Who Paid My Doc
Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age
ClinicalTrials.gov NCT05992935
Research payments
$3,261,761
Through program year 2025, $3,261,761 in research payments was reported against Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age, across 435 payments, paid by Moderna TX, Inc..
- Paid by
- Moderna TX, Inc.
- ClinicalTrials.gov
- NCT05992935
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $3,261,761 | 435 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Hareshkumar Boghara Desoto, TX Named on 57 payments
- Mark Turner Meridian, ID Named on 49 payments
- Shishir Khetan Rockville, MD Named on 43 payments
- Charles Harper Norfolk, NE Named on 40 payments
- David Ensz South Sioux City, NE Named on 37 payments
- Frederick Raiser Omaha, NE Named on 33 payments
- Clint Flanagan Dacono, CO Named on 29 payments
- Marshall Nash Decatur, GA Named on 29 payments
- Matthew Davis Rochester, NY Named on 25 payments
- Todd Bertoch Salt Lake City, UT Named on 22 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.